慢性冠状动脉疾病的策略:临床医生简要指南
Chayakrit Krittanawong1, Muzamil Khawaja2, Hafeez Ul Hassan Virk3
1Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY, USA. Chayakrit.Krittanawong@va.gov.
NPJ cardiovascular health
|March 3, 2026
概括
2023年美国心脏协会/美国心脏病学院的指导方针强调改变生活方式和治疗慢性冠状动脉疾病 (CCD) 的药物管理. 这些策略改善了心血管结果,并减少了CCD患者的死亡率.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
背景情况:
- 慢性冠状动脉疾病 (CCD) 的管理需要全面的战略.
- 美国心脏协会 (AHA) 和美国心脏病学院 (ACC) 在2023年发布了更新的指南.
- 有效的CCD护理整合了多种治疗方式.
研究的目的:
- 审查2023年AHA/ACC关于慢性冠状动脉疾病 (CCD) 管理的指南.
- 强调非药理和药理干预的重要性.
- 增强对导致改善CCD患者心血管结果的方法的理解.
主要方法:
- 审查2023年多社会指南的慢性冠状动脉疾病 (CCD) 患者的管理.
- 对非药物干预 (生活方式改变) 的分析.
- 对药理学和重血管化治疗的分析.
主要成果:
- 非药物干预措施,如增加体力活动,均衡饮食和戒烟至关重要.
- 药理疗法和再血管化优化心脏功能,减少不良事件.
- 结合生活方式的改变和药物改善生活质量,降低死亡率.
结论:
- 遵守2023年AHA/ACC指南对于最佳的CCD患者护理至关重要.
- 必须采取多方面的方法,包括改变生活方式和基于证据的治疗方法.
- 综合管理策略显著提高心血管结果和患者存活率.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Angina IV: Management
495
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495
Angina V: Nursing Management
567
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
567
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


